|
Now, I can practically hear what you’re thinking at this point: If it’s that good, why haven’t I heard of it? Trust me — it's that good. And although you could not have heard of it, researchers have. It’s been studied for decades now — along with the science behind it's rock solid. In fact, if this was a movie, I could make a poster filled with glowing blurbs — like this one from the journal Diabetes/Metabolism Research and Reviews: “an inexpensive approach to the prevention and/or treatment of diabetic complications.” Or perhaps this one, from Pharmacological Research: “effective for the treatment of diabetic neuropathy, nephropathy and retinopathy.” Circulation: Heart Failure: “protects from diabetes mellitus-induced cardiac dysfunction” and “merits attention for application in clinical practice.” Even in other languages, the results are the exact same — this was in Serbian Archives for the Entire Medicine last year: “significant subjective and objective improvement” and “a excellent starting choice” for diabetic polyneuropathy. I didn’t cherry-pick these, by the way. You'll be able to look it up yourself in the event you want — and you’ll uncover that the glowing research isn’t limited to diabetes. Other studies have discovered that benfotiamine could assist treat or lower the risk of everything from Alzheimer’s disease to heart problems.
|
